Why MedTech’s Most Critical Leadership Gap Is Getting Harder to Ignore
Every engineering team under schedule pressure makes tradeoffs. Document it later. Close the risk gap after the milestone. Patch the test protocol after verification. These decisions accumulate quietly—until a 510(k) rejection, an FDA inspection, or a post-market complaint forces a reckoning that costs orders of magnitude more than the original shortcut.
Proton Therapy as a Case Study in Systems IntegrationEngineering, Regulatory, and Operations at the Frontier
A particle accelerator. A 100-ton rotating gantry. 20 major assemblies from across the globe. 50+ international safety standards as design inputs. One FDA 510(k) submission. This is what real systems integration complexity looks like—and what it teaches about every program that follows.
Beyond Compliance: How Strategic Risk Analysis Drives Value Creation in Medical Device Development
Risk analysis isn’t a checkbox — it’s a competitive moat. Companies that master ISO 14971’s layered approach (Hazard Analysis → DFMEA → PFMEA → UFMEA) prevent recalls, accelerate approvals, and build patient trust. Here’s how.